Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation.

[1]  F. Alt,et al.  Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction , 1998, Current Biology.

[2]  K. Tedford,et al.  Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor , 1998, Current Biology.

[3]  Yan Wu,et al.  Tyrosine Phosphorylation Regulates the SH3-mediated Binding of the Wiskott-Aldrich Syndrome Protein to PSTPIP, a Cytoskeletal-associated Protein* , 1998, The Journal of Biological Chemistry.

[4]  A. Weiss,et al.  Cytoskeletal Polarization of T Cells Is Regulated by an Immunoreceptor Tyrosine-based Activation Motif–dependent Mechanism , 1998, The Journal of cell biology.

[5]  A. Hall,et al.  Rho GTPases and the actin cytoskeleton. , 1998, Science.

[6]  Yoshimi Takai,et al.  Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP , 1998, Nature.

[7]  J. Hartwig,et al.  WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Fox,et al.  Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora , 1997, Infection and immunity.

[9]  M. Gallego,et al.  Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation , 1997 .

[10]  S. Kanner,et al.  Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. , 1997, Blood.

[11]  F. Finkelman,et al.  Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. , 1997, Journal of immunology.

[12]  E. Mizoguchi,et al.  Role of cytokines in the early stages of chronic colitis in TCR alpha-mutant mice. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[13]  Rong Li,et al.  Bee1, a Yeast Protein with Homology to Wiscott-Aldrich Syndrome Protein, Is Critical for the Assembly of Cortical Actin Cytoskeleton , 1997, The Journal of cell biology.

[14]  M. Olson,et al.  Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases , 1996, Current Biology.

[15]  S. Snapper,et al.  Probing the gastrointestinal immune function using transgenic and knockout technology , 1996 .

[16]  R C Lovering,et al.  Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. , 1996, Journal of immunology.

[17]  K. Schwarz.  WASPbase: a database of WAS- and XLT-causing mutations. , 1996, Immunology today.

[18]  P. Finan,et al.  Identification of Regions of the Wiskott-Aldrich Syndrome Protein Responsible for Association with Selected Src Homology 3 Domains* , 1996, The Journal of Biological Chemistry.

[19]  R. Rickles,et al.  Identification of Itk/Tsk Src Homology 3 Domain Ligands* , 1996, The Journal of Biological Chemistry.

[20]  K. Miura,et al.  N‐WASP, a novel actin‐depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2‐dependent manner downstream of tyrosine kinases. , 1996, The EMBO journal.

[21]  I. Gout,et al.  Wiskott–Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases , 1996, Current Biology.

[22]  T. Kirchhausen,et al.  Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Remold-O’Donnell,et al.  Defects in Wiskott-Aldrich syndrome blood cells. , 1996, Blood.

[24]  P. Leder,et al.  Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.

[25]  U. Francke,et al.  Wiskott–Aldrich Syndrome Protein, a Novel Effector for the GTPase CDC42Hs, Is Implicated in Actin Polymerization , 1996, Cell.

[26]  J. Ward,et al.  Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. , 1996, Laboratory animal science.

[27]  Uno Lindberg,et al.  Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott–Aldrich syndrome , 1996, Current Biology.

[28]  U. Francke,et al.  The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. , 1995, Blood.

[29]  A. Marcilla,et al.  Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains , 1995, Molecular and cellular biology.

[30]  F. Alt,et al.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.

[31]  R. Blaese,et al.  Scanning of the Wiskott-Aldrich syndrome (WAS) gene: identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. , 1995, Human molecular genetics.

[32]  U. Francke,et al.  The mouse homolog of the Wiskott-Aldrich syndrome protein (WASP) gene is highly conserved and maps near the scurfy (sf) mutation on the X chromosome. , 1995, Genomics.

[33]  X. Estivill,et al.  WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. , 1995, Human molecular genetics.

[34]  R. Blaese,et al.  Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Nobes,et al.  Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia , 1995, Cell.

[36]  M. Barbacid,et al.  Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.

[37]  F. Alt,et al.  Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.

[38]  K. Rajewsky,et al.  Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.

[39]  T. Roszman,et al.  cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization , 1995, Journal of Neuroimmunology.

[40]  U. Francke,et al.  Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.

[41]  B. Zegers,et al.  Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome. , 1994, Journal of immunology.

[42]  P. Phatak,et al.  Engagement of the T‐cell antigen receptor by anti‐CD3 monoclonal antibody causes a rapid increase in lymphocyte F‐actin , 1994, Journal of cellular physiology.

[43]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[44]  S. Tonegawa,et al.  Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice , 1993, Cell.

[45]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[46]  C. Terhorst,et al.  T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. , 1993, Journal of immunology.

[47]  G K Lewis,et al.  Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells. , 1993, Journal of immunology.

[48]  V. Stewart,et al.  RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  G. Mills,et al.  Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. , 1992, The Journal of clinical investigation.

[50]  E. Remold-O’Donnell,et al.  T cell lines characterize events in the pathogenesis of the Wiskott- Aldrich syndrome , 1992, The Journal of experimental medicine.

[51]  R. Pardi,et al.  Antigen-receptor complex stimulation triggers protein kinase C- dependent CD11a/CD18-cytoskeleton association in T lymphocytes , 1992, The Journal of cell biology.

[52]  G. Downey,et al.  Microfilament assembly is required for antigen-receptor-mediated activation of human B lymphocytes. , 1991, Journal of immunology.

[53]  J. Ott,et al.  Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22-Xp11.3. , 1991, Genomics.

[54]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[55]  M. Chang,et al.  Wiskott-Aldrich syndrome and inflammatory bowel disease. , 1988, Annals of allergy.

[56]  R. Parkman,et al.  Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. , 1986, Blood.

[57]  J. Smith,et al.  Capping of human T cell specific determinants: kinetics of capping and receptor re-expression and regulation by the cytoskeleton. , 1983, Journal of immunology.

[58]  L. Harker,et al.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets , 1980 .

[59]  S. D. Petris,et al.  Inhibition and reversal of capping by cytochalasin B, yinblastine and colchicine , 1974, Nature.

[60]  M. Raff,et al.  Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody. , 1971, Nature: New biology.

[61]  T. Waldmann,et al.  The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. , 1968, Lancet.

[62]  M. Cooper,et al.  Wiskott-Aldrich syndrome: An immunologic deficiency disease involving the afferent limb of immunity , 1968 .

[63]  R. Weston,et al.  GENETIC STUDIES BY RECORD LINKAGE. , 1965, Lancet.